Article
No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome.
Human genetics - 1 Dec 1997
Pesso R, Barkai G, Ravia Y, Gak E, Frydman M, Goldman B, Friedman E
Abstract excerpt
Several studies on small homogenous populations suggested that fragile-X syndrome originated from a limited number of founder chromosomes. The Israeli Jewish population could serve as an adequate model for tracing a founder effect due to the unique ethnic makeup and traditional lifestyle. Furthermore, a common haplotype for Jewish Tunisian fragile X patients was recently reported. To test for a similar occurrence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
